Tradestie Institutional Equity Comparison Engine
KTTA vs SBEV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KTTA Overall Edge
KTTA Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus SBEV at N/M Forward P/E and -23888.5% operating margin (-93.8% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBEV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
KTTA N/M vs SBEV N/M Fwd P/E
Growth & Margin Winner
KTTA
Op Margin 0.0% vs -23888.5% ยท YoY +1498.1% vs -93.8%
Momentum & Technical Winner
KTTA
1Y +0.6% vs -73.4% ยท 52W Pos 11% vs 12%
Options & Structure Winner
KTTA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA
NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap
$17.7M
1M Return
+7.52%
1Y Return
+0.59%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 20.0
Fund 40.0
Flow 50.0
Mom 60.0
SBEV
NYSE American
Splash Beverage Group, Inc.
Beverages
$0.47
+10.94% 1D
Market Cap
$2.7M
1M Return
+358.21%
1Y Return
-73.38%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 15.0
Fund 32.0
Flow 44.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KTTA +0.59%
SBEV -73.38%
Spread: +61.13 pp (KTTA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KTTA Revenue | SBEV Revenue | KTTA Op. Margin | SBEV Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | 5.1% | SBEV |
| FY2019 | N/A | $0M | N/A | -22009.4% | SBEV |
| FY2020 | N/A | $0M | N/A | -767.9% | SBEV |
| FY2021 | $0M | $10M | -29925.7% | -257.0% | SBEV |
| FY2022 | $0M | $20M | -2587.3% | -118.3% | SBEV |
| FY2023 | N/A | $20M | N/A | -81.1% | SBEV |
| FY2024 | N/A | $0M | N/A | -1235.6% | SBEV |
| FY2025 | N/A | $0M | N/A | -19415.6% | SBEV |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KTTA | SBEV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $17.7M | $2.7M | Larger Scale | KTTA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +1498.1% | -93.8% | Higher Growth | KTTA |
| Operating Margin (TTM) Profitability | 0.0% | -23888.5% | Higher Margin | KTTA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -88.8% | -1130.2% | Higher ROE | KTTA |
| 52-Week Range Position Momentum | 11% ($0โ$2) | 12% ($0โ$3) | Stronger Trend | SBEV |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 185% Vol | -1.41ฮฒ ยท 136% Vol | Lower Realized Risk | SBEV |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 36.4 / 100 (SELL) | Higher Composite | KTTA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KTTA vs SBEV Buy Guide
KTTA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SBEV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KTTA nor SBEV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.